Catalent’s CHO cell lines and Gate’s Foundation to make PATH Malaria vaccine
Catalent has partnered with US non-profit PATH for antibody discovery using the CDMO’s GPEx cell line platform, funded by PATH’s Malaria Vaccine Initiative (MVI).
Archives for December 21, 2016
AGC expanding CDMO biz through $500m CMC Biologics buy
AGC Asahi Glass has signed an agreement to buy CMC Biologics, the second biologics CDMO acquisition for the Japanese chemicals firm in three months.
Wacker adding cysteine capacity through Spanish acquisition
Wacker says it is buying a large-scale fermentation facility in Spain to support growing demand for the amino acid cysteine.